Clinical Trials Browser

Phase 1/2 × Prostatic Neoplasms, Castration-Resistant × 90 days × Clear all

NCT06863272 2026-03-16

IDeate-Prostate02

Phase 1/2 Recruiting

Neoplasm Metastasis, Prostatic Neoplasms, Castration-Resistant

NCT07258407 2026-03-16

A Clinical Trial Evaluating the Safety of TD001 In Patients With PSMA-Expressing Metastatic Prostate Cancer

Phase 1/2 Recruiting

Prostatic Neoplasms, Castration-Resistant

NCT06353386 2026-03-13

MK-5684-01A

Phase 1/2 Recruiting

Prostatic Neoplasms, Castration-Resistant